Two Patients With Advanced-Stage Lung Adenocarcinoma With Radiologic Complete Response to Nivolumab Treatment Harboring an STK11/ LKB1 Mutation

JCO Precis Oncol. 2020 Nov:4:1239-1245. doi: 10.1200/PO.20.00174.

Ernest Nadal¹, Simon Heeke^{2

3}, Jonathan Benzaquen^{2

3}, Noelia Vilariño¹, Arturo Navarro⁴, Daniel Azuara⁵, Mar Varela⁶, Josiane Otto⁷, Nuria Baixeras⁶, David Shahbazian⁸, Pascal Puchois⁸, Sarah E Church⁹, Thomas H Smith⁹, Elisabeth Lanteri^{2

3}, Marius Ilié^{2

3

10}, Paul Hofman^{2

3

10}

¹ Department of Medical Oncology, Catalan Institute of Oncology, Oncobell Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain.
² Laboratory of Clinical and Experimental Pathology, Centre Hospitalier Universitaire (CHU) of Nice, Nice, France.
³ Université Côte D'Azur, Nice, France.
⁴ Department of Radiation Oncology, Catalan Institute of Oncology, Oncobell Program, IDIBELL, L'Hospitalet de Llobregat, Spain.
⁵ Translational Research Laboratory, Catalan Institute of Oncology, Oncobell Program, IDIBELL, L'Hospitalet de Llobregat, Spain.
⁶ Department of Pathology, Hospital Universitari de Bellvitge, L'Hospitalet, Barcelona, Spain.
⁷ Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France.
⁸ Trans-Hit Biomarkers, Laval, Quebec, Canada.
⁹ NanoString Technologies, Seattle, WA.
¹⁰ FHU OncoAge, Nice, France.

No abstract available